IXHL - What's Going On With Incannex Stock? | Benzinga
Incannex Healthcare Inc. (NASDAQ:IXHL) shares are trading higher Wednesday after the company announced its Psi-GAD1 trial met its primary endpoint.
The Details:
Incannex said that its Phase 2 Psi-GAD1 clinical trial of psilocybin in generalized anxiety disorder met its primary endpoint of demonstrating a large clinical effect in the psilocybin treatment group over the ...